Philippines government investigates Dengvaxia dengue vaccine

Philippines government investigates Dengvaxia dengue vaccine

Dengue Vaccine Controversy

Last week, the Philippines' health department suspended the vaccination after Sanofi announced evidence showing that people who receive the vaccine, known as Dengvaxia, without previous dengue infection could face the risk of their disease worsening.

The country's public immunization program was suspended on Friday.

The country was among the first to use Dengvaxia on children at least nine years old.

The report also said there was no knowing for the time being if the Philippines health officials had been aware of the risks involved with the vaccine.

Some good news? USA researchers have found that a Zika vaccine, which Sanofi dropped in September over pricing, produced strong responses in more than 90% of those taking part in an early-stage clinical trial.

Sanofi Pasteur, the vaccine division of Sanofi, announced today that the world's first dengue vaccine could be available in the second half of 2015.

The vaccine so far has been approved in 19 countries and launched in 11, Sanofi said.

The outcry of dengue in Southeast Asia and the confusion and concern regarding its vaccine in the Philippines is something people in and moving to the region must be wary of, as many may be rushing to protect themselves and their family from various exotic diseases.

Netflix cuts ties with Danny Masterson after rape allegations
Actor Danny Masterson has been written out of the Netflix show " The Ranch " following mounting allegations of rape. However, in the current political climate, it seems as if you are presumed guilty the moment you are accused.

Anvisa did not immediately respond to a request for comment, nor did the Health Ministry.

A spokesman for Philippines President Rodrigo Duterte said on Sunday the government would hold to account those responsible for the program.

Justice Secretary Vitaliano Aguirre II said that he would tap the National Bureau of Investigation (NBI) to initiate a fact-finding investigation to determine possible accountabilities of officials behind the purchase that was approved by former health chief Janette Garin.

The Department of Health procured P3 billion worth of Dengvaxia intended for one million public school children in areas reported to have the highest incidence of dengue in the same year.

Presidential spokesman Harry Roque said there had been no reported case of severe dengue infection since the vaccine was administered and urged the public "not to spread information that may cause undue alarm".

"When we evaluated the clinical records, it was not related to the dengue vaccination", Bayugo said.

Dengue is a mosquito-borne tropical disease that kills about 20,000 people a year and infects hundreds of millions.

"Like many others in the Philippines, WHO is awaiting the expert analysis of new data and advice about its implications for use of the vaccine".

Latest News